Name:	O
___	O
Unit	O
No:	O
___	O
Admission	O
Date:	O
___	O
Discharge	O
Date:	O
___	O
Date	O
of	O
Birth:	O
___	O
Sex:	O
F	O
Service:	O
MEDICINE	O
Allergies:	O
Sulfa(Sulfonamide	O
Antibiotics)	O
/	O
prednisone	O
/	O
simvastatin	O
Attending:	O
___.	O
Chief	O
Complaint:	O
Bacteremia	O
Major	O
Surgical	O
or	O
Invasive	O
Procedure:	O
1.	O
ERCP	O
2.	O
TEE	O
History	O
of	O
Present	O
Illness:	O
Ms.	O
___	O
is	O
an	O
___	O
with	O
a	O
PMHx	O
significant	O
for	O
CHF,	O
DMII,	O
HLD,	O
HTN,	O
and	O
Afib	O
on	O
coumadin	O
who	O
was	O
found	O
to	O
be	O
bacteremic	O
with	O
strep	O
gallolyticus	O
now	O
on	O
CTX	O
at	O
___,	O
and	O
was	O
transfered	O
to	O
___	O
after	O
a	O
CT	O
revealed	O
a	O
distal	O
CBD	O
stone	O
requiring	O
ERCP	O
evaluation.	O
Ms.	O
___	O
was	O
initially	O
brought	O
to	O
___	O
approximately	O
on	O
___	O
for	O
confusion,	B-Delirium
fevers,	O
and	O
chills.	O
Here,	O
she	O
was	O
thought	O
to	O
have	O
urosepsis	B-Urinary_tract_infection
because	O
she	O
reported	O
difficulty	O
with	O
urination	O
and	O
was	O
treated	O
with	O
levofloxacin.	O
After	O
her	O
blood	O
culture	O
grew	O
step	O
gallolyticus,	O
she	O
was	O
broadened	O
to	O
vanc/levo	O
before	O
ID	O
recommended	O
monotherapy	O
with	O
CTX.	O
At	O
admission,	O
her	O
labs	O
were	O
as	O
follows:	O
WBC	O
9.4,	O
Hgb	O
12.6,	O
plt	O
192	O
Na	O
141,	O
K	O
3.7,	O
Cl	O
101,	O
CO2	O
28,	O
Glu	O
179,	O
BUN	O
25,	O
Cr	O
0.8,	O
Ca	O
9.5	O
Lactate	O
1.4	O
Digoxin	O
0.8	O
UA	O
cloudy,	O
blood	O
trace,	O
protein	O
300,	O
nitrite	O
neg,	O
___	O
large,	O
WBC	O
___,	O
RBC	O
___.	O
___	O
BCx	O
has	O
no	O
growth	O
to	O
date	O
Importantly,	O
Ms.	O
___	O
was	O
previously	O
at	O
the	O
___	O
for	O
an	O
aortic	O
___	O
procedure	O
in	O
___.	O
Given	O
this,	O
she	O
is	O
at	O
risk	O
for	O
endocarditis	O
and	O
will	O
require	O
TEE	O
while	O
in	O
house	O
for	O
evaluation.	O
Currently,	O
patient	O
is	O
alert,	O
oriented,	B-Delirium
and	O
without	O
complaints.	O
Past	O
Medical	O
History:	O
hepatitis	O
B	O
diagnosed	O
___	O
diabetes	O
type	O
II	O
critical	O
aortic	O
stenosis	O
atrial	O
fibrillation	O
arthritis	O
hypertension	O
Spinal	O
stenosis	O
Macular	B-Visual_impairment
degeneration	B-Visual_impairment
Past	O
Surgical	O
History:	O
right	O
knee	O
replacement	O
___	O
back	O
surgery	O
(spinal	O
stenosis)	O
appendectomy	O
Social	O
History:	O
___	O
Family	O
History:	O
No	O
family	O
history	O
of	O
early	O
MI,	O
arrhythmia,	O
cardiomyopathies,	O
or	O
sudden	O
cardiac	O
death;	O
otherwise	O
non-contributory.	O
Mother	O
passed	O
away	O
from	O
pancreatic	O
cancer.	O
Family	O
hx	O
HTN.	O
Physical	O
Exam:	O
At	O
Admission:	O
General:	O
NAD,	O
very	O
pleasant	O
elderly	O
woman	O
laying	O
in	O
bed.	O
HEENT:	O
NC/AT,	O
PERRL,	O
EOMI,	O
MMM	O
Neck:	O
No	O
JVD,	O
no	O
thyromegaly	O
Lungs:	O
CTAB,	O
no	O
wheeze	O
or	O
crackles	O
Cardiovascular:	O
S1	O
and	O
S2	O
appreciated,	O
no	O
m/r/g	O
Abdomen:	O
SNTND,	O
without	O
hepatosplenomegaly	O
Neurologic	O
Examination:	O
Alert	O
and	O
Oriented	B-Delirium
x	B-Delirium
3	B-Delirium
Skin:	O
No	O
clubbing	O
or	O
cyanosis.	O
She	O
does	O
have	O
two	O
brown	O
macules	O
on	O
left	O
plantar	O
food	O
and	O
right	O
shin	O
and	O
various	O
scar	O
biopsies	O
At	O
Discharge:	O
VS:	O
98.3	O
141/63,	O
62,	O
18,	O
98%RA	O
General:	O
NAD,	O
very	O
pleasant	O
elderly	O
woman	O
laying	O
in	O
bed.	O
HEENT:	O
NC/AT,	O
PERRL,	O
EOMI,	O
MMM	O
Neck:	O
No	O
JVD,	O
no	O
thyromegaly	O
Lungs:	O
CTAB,	O
no	O
wheeze	O
or	O
crackles	O
Cardiovascular:	O
S1	O
and	O
S2	O
appreciated,	O
no	O
m/r/g	O
Abdomen:	O
SNTND,	O
without	O
hepatosplenomegaly	O
Neurologic	O
Examination:	O
Alert	O
and	O
Oriented	B-Delirium
x	B-Delirium
3	B-Delirium
Skin:	O
No	O
clubbing	O
or	O
cyanosis.	O
She	O
does	O
have	O
two	O
brown	O
macules	O
on	O
left	O
plantar	O
food	O
and	O
right	O
shin	O
and	O
various	O
scar	O
biopsies	O
Pertinent	O
Results:	O
At	O
Admission:	O
___	O
06:30AM	O
BLOOD	O
WBC-5.6	O
RBC-3.52*	O
Hgb-11.7*	O
Hct-33.8*	O
MCV-96	O
MCH-33.4*	O
MCHC-34.7	O
RDW-12.2	O
Plt	O
___	O
___	O
06:30AM	O
BLOOD	O
Glucose-125*	O
UreaN-25*	O
Creat-0.7	O
Na-144	O
K-3.8	O
Cl-104	O
HCO3-31	O
AnGap-13	O
___	O
06:30AM	O
BLOOD	O
ALT-40	O
AST-29	O
AlkPhos-87	O
TotBili-0.4	O
___	O
06:40AM	O
BLOOD	O
CRP-23.1*	O
At	O
Discharge:	O
___	O
WBC-5.6	O
RBC-3.03*	O
Hgb-9.7*	O
Hct-29.0*	O
MCV-96	O
MCH-32.1*	O
MCHC-33.5	O
RDW-12.0	O
Plt	O
___	O
BLOOD	O
___	O
PTT-30.5	O
___	O
BLOOD	O
Plt	O
___	O
Glucose-102*	O
UreaN-21*	O
Creat-0.6	O
Na-142	O
K-3.9	O
Cl-103	O
HCO3-33*	O
AnGap-10	O
ALT-35	O
AST-28	O
AlkPhos-75	O
TotBili-0.7	O
MISC	O
LABS:	O
___	O
BLOOD	O
ESR-37*	O
___	O
BLOOD	O
proBNP-1177*	O
___	O
BLOOD	O
CRP-23.1*	O
Studies:	O
___	O
CXR	O
IMPRESSION:	O
Right	O
PICC	O
line	O
terminates	O
in	O
mid-to-low	O
SVC.	O
No	O
pneumothorax.	O
ECHO	O
___	O
IMPRESSION:	O
No	O
transesophageal	O
echocardiographic	O
evidence	O
of	O
valvular	O
vegetations	O
or	O
abscesses.	O
Normal	O
global	O
biventricular	O
systolic	O
function.	O
Well	O
seated	O
aortic	O
___	O
prosthesis	O
with	O
minimal	O
paravalvular	O
leak.	O
Mild	O
to	O
moderate	O
mitral	O
regurgitation.	O
Moderate	O
tricuspid	O
regurgitation.	O
Simple	O
atheroma	O
descending	O
thoracic	O
aorta	O
and	O
aortic	O
arch.	O
CT	O
abdomen	O
___	O
1.	O
Uncomplicated	O
colonic	O
diverticulosis.	O
Scattered	O
hepatic	O
cysts,	O
calcified	O
granulomata.	O
Unchanged	O
since	O
___.	O
2.	O
Bilateral	O
renal	O
atrtery	O
small	O
aneurysms,	O
2	O
splenic	O
hilum	O
level	O
splenic	O
artery	O
aneurysms,	O
unchanged	O
from	O
___.	O
3.	O
Gallstones	O
without	O
evidence	O
for	O
cholecystitis.	O
Distal	O
CBC	O
calculus	O
ovserved,	O
associated	O
with	O
mild	O
intra/extra	O
hepatic	O
bile	O
duct	O
dilatation	O
(12mm).	O
4.	O
Mild	O
constipation.	B-Constipation
No	O
definite	O
bowel	O
mass.	O
CT	O
of	O
abd	O
and	O
pelvis	O
with	O
full	O
3	O
hours	O
or	O
more	O
prep	O
enteric	O
contrast	O
may	O
increase	O
confidence	O
of	O
negative	O
result.	O
ECG	O
___:	O
Atrial	O
fibrillation	O
with	O
PVCs.	O
LAD.	O
Poor	O
R	O
wave	O
progression,	O
probably	O
normal	O
variant.	O
Non	O
specific	O
lateral	O
ST	O
T	O
changes.	O
Procedure:	O
A	O
sphincterotomy	O
was	O
performed	O
in	O
the	O
12	O
o'clock	O
position	O
using	O
a	O
sphincterotome	O
over	O
an	O
existing	O
guidewire.	O
Then,	O
a	O
sphincteroplasty	O
was	O
performed	O
using	O
a	O
CRE	O
balloon	O
from	O
10	O
mm	O
to	O
12	O
mm	O
over	O
an	O
existing	O
wire.	O
Several	O
balloon	O
sweeps	O
were	O
performed.	O
Three	O
large	O
stones	O
and	O
small	O
fragments	O
of	O
stones	O
were	O
extracted	O
successfully	O
using	O
a	O
balloon.	O
Final	O
cholangiogram	O
showed	O
no	O
filling	O
defects.	O
Excellent	O
flow	O
of	O
bile	O
was	O
noted.	O
Impression:	O
Normal	O
major	O
papilla	O
Cannulation	O
of	O
the	O
biliary	O
duct	O
was	O
successful	O
and	O
deep	O
with	O
a	O
___	O
tapered	O
catheter	O
A	O
moderate	O
diffuse	O
dilation	O
was	O
seen	O
at	O
the	O
biliary	O
tree	O
with	O
the	O
CBD	O
measuring	O
12	O
mm.	O
There	O
were	O
several	O
filling	O
defects	O
in	O
the	O
common	O
bile	O
duct	O
compatible	O
with	O
stones.	O
A	O
sphincterotomy	O
was	O
performed	O
Several	O
balloon	O
sweeps	O
were	O
performed.	O
Three	O
large	O
stones	O
and	O
small	O
fragments	O
of	O
stones	O
were	O
extracted	O
successfully	O
using	O
a	O
balloon.	O
Final	O
cholangiogram	O
showed	O
no	O
filling	O
defects.	O
Excellent	O
flow	O
of	O
bile	O
was	O
noted.	O
Brief	O
Hospital	O
Course:	O
-Principle	O
Reason	O
for	O
Admission-	O
Ms.	O
___	O
is	O
an	O
___	O
who	O
was	O
found	O
to	O
be	O
bacteremic	O
with	O
strep	O
gallolyticus	O
now	O
on	O
CTX	O
at	O
___,	O
and	O
was	O
transfered	O
to	O
___	O
after	O
a	O
CT	O
revealed	O
a	O
CBD	O
stone	O
requiring	O
ERCP	O
evaluation.	O
#Bacteremia:	O
Found	O
to	O
be	O
growing	O
Strep	O
gallolyticus	O
at	O
OSH.	O
OSH	O
___	O
BCx	O
and	O
___	O
___	O
BCx	O
have	O
no	O
growth	O
to	O
date	O
as	O
she	O
is	O
being	O
treated	O
with	O
2mg	O
IV	O
ceftriaxone	O
Q24.	O
She	O
has	O
been	O
asymptomatic,	O
afebrile	O
and	O
HDS	O
throughout	O
her	O
admission.	O
Clinically,	O
she	O
did	O
not	O
have	O
a	O
murmor	O
on	O
exam,	O
but	O
given	O
that	O
she	O
is	O
at	O
risk	O
for	O
endocarditis	O
from	O
her	O
Aortic	O
valve	O
replacement,	O
she	O
received	O
a	O
TEE	O
that	O
showed	O
normal	O
valves	O
without	O
vegtation	O
or	O
infection.	O
ID	O
was	O
consulted	O
and	O
recommend	O
4	O
weeks	O
of	O
IV	O
CTX	O
treatment	O
(start	O
date:	O
___	O
and	O
follow	O
up	O
in	O
their	O
clinic.	O
Pt	O
offered	O
inpatient	O
colonoscopy	O
but	O
declined,	O
would	O
readdress	O
as	O
outpatient.	O
#	O
Choledocolithiasis	O
with	O
obstruction:	O
ERCP	O
was	O
successful	O
and	O
uncomplicated,	O
removed	O
stones	O
and	O
performed	O
a	O
sphincterotomy.	O
#	O
Atrial	O
fibrillation:	O
Patient	O
with	O
history	O
of	O
chronic	O
Afib	O
on	O
coumadin,	O
diltiazem,	O
and	O
digoxin	O
at	O
home.	O
Coumadin	O
was	O
held	O
at	O
OSH	O
for	O
anticipation	O
of	O
ERCP,	O
but	O
was	O
restarted	O
prior	O
to	O
discharge.	O
Follow	O
up	O
with	O
INR	O
will	O
be	O
necessary.	O
INR	O
at	O
d/c	O
was	O
1.8,	O
please	O
check	O
INR	O
on	O
___,	O
goal	O
INR	O
___.	O
#	O
___	O
Study	O
Eval:	O
Patient	O
had	O
multiple	O
tests	O
conducted	O
during	O
this	O
admission	O
for	O
her	O
___	O
AVR	O
study.	O
Chronic	O
Problems	O
#	O
Hypertension:	O
Patient	O
on	O
home	O
regimen	O
of	O
lisinopril,	O
diltiazem,	O
lasix.	O
#	O
Diabetes:	O
Januvia	O
will	O
be	O
held	O
while	O
in	O
house.	O
Control	O
with	O
HISS.	O
#	O
Spinal	O
stenosis:	O
No	O
current	O
symtpoms.	O
Physical	O
therapy	O
will	O
work	O
with	O
the	O
patient	O
while	O
in	O
house.	O
-Transitions	O
of	O
Care-	O
1.	O
The	O
ERCP	O
was	O
successful	O
and	O
without	O
complication,	O
but	O
did	O
not	O
reveal	O
the	O
etiology	O
of	O
her	O
infection.	O
Given	O
this,	O
she	O
may	O
need	O
a	O
colonoscopy	O
to	O
better	O
evaluate	O
her	O
colon	O
for	O
another	O
source	O
of	O
the	O
infection.	O
However,	O
she	O
adamantly	O
reports	O
that	O
she	O
does	O
not	O
want	O
to	O
a	O
colonoscopy.	O
This	O
conversation	O
should	O
be	O
had	O
with	O
her,	O
her	O
son,	O
and	O
her	O
PCP	O
in	O
the	O
outpatient	O
setting.	O
2.	O
Per	O
our	O
ID	O
team,	O
she	O
will	O
require	O
4	O
weeks	O
of	O
CTX	O
treatment	O
for	O
the	O
bacteremia	O
(day	O
1=	O
___	O
because	O
of	O
her	O
prosthetic	O
valve.	O
3.	O
She	O
has	O
an	O
appointment	O
to	O
meet	O
with	O
the	O
___	O
ID	O
team	O
in	O
4	O
weeks.	O
She	O
will	O
require	O
weekly	O
CBC/Diff,	O
BUN/Creat.,	O
LFTs,	O
and	O
ESR/CRP	O
faxed	O
to	O
___.	O
4.	O
Follow	O
up	O
INR,	O
goal	O
___.	O
5.	O
Rehab	O
for	O
less	O
than	O
30	O
days.	O
Medications	O
on	O
Admission:	O
The	O
Preadmission	O
Medication	O
list	O
is	O
accurate	O
and	O
complete.	O
1.	O
CeftriaXONE	O
2	O
gm	O
IV	O
Q24H	O
2.	O
Warfarin	O
2.5	O
mg	O
PO	O
DAILY16	O
3.	O
Ezetimibe	O
10	O
mg	O
PO	O
DAILY	O
4.	O
TraZODone	O
25	O
mg	O
PO	O
HS	O
5.	O
Digoxin	O
0.125	O
mg	O
PO	O
MTTHSAT	O
6.	O
Senna	O
Dose	O
is	O
Unknown	O
PO	O
Frequency	O
is	O
Unknown	O
7.	O
Acetaminophen	O
Dose	O
is	O
Unknown	O
PO	O
Frequency	O
is	O
Unknown	O
8.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
9.	O
sitaGLIPtin	O
*NF*	O
25	O
mg	O
Oral	O
daily	O
10.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
11.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
12.	O
Diltiazem	O
Extended-Release	O
240	O
mg	O
PO	O
DAILY	O
13.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
14.	O
Calcium	O
Carbonate	O
Dose	O
is	O
Unknown	O
PO	O
Frequency	O
is	O
Unknown	O
15.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
16.	O
Fish	O
Oil	O
(Omega	O
3)	O
Dose	O
is	O
Unknown	O
PO	O
Frequency	O
is	O
Unknown	O
Discharge	O
Medications:	O
1.	O
Acetaminophen	O
650	O
mg	O
PO	O
Q8H:PRN	O
Pain	O
2.	O
Aspirin	O
81	O
mg	O
PO	O
DAILY	O
3.	O
CeftriaXONE	O
2	O
gm	O
IV	O
Q24H	O
Strep	O
Bovis	O
Bacteremia	O
4.	O
Digoxin	O
0.125	O
mg	O
PO	O
___	O
Hold	O
if	O
SBP	O
<100	O
or	O
HR<60.	O
5.	O
Diltiazem	O
Extended-Release	O
240	O
mg	O
PO	O
DAILY	O
Hold	O
if	O
SBP<100	O
or	O
HR<60.	O
6.	O
Ezetimibe	O
10	O
mg	O
PO	O
DAILY	O
7.	O
Furosemide	O
20	O
mg	O
PO	O
DAILY	O
CHF	O
Hold	O
if	O
SBP<100	O
or	O
HR<60.	O
8.	O
Lisinopril	O
5	O
mg	O
PO	O
DAILY	O
HTN	O
Hold	O
if	O
SBP<100	O
or	O
HR<60.	O
9.	O
TraZODone	O
25	O
mg	O
PO	O
HS:PRN	O
insomnia	O
10.	O
Vitamin	O
D	O
1000	O
UNIT	O
PO	O
DAILY	O
11.	O
Warfarin	O
2.5	O
mg	O
PO	O
DAILY16	O
12.	O
Calcium	O
Carbonate	O
500	O
mg	O
PO	O
QD	O
Dose	O
was	O
unknown,	O
please	O
give	O
at	O
home	O
dose	O
13.	O
Fish	O
Oil	O
(Omega	O
3)	O
1000	O
mg	O
PO	O
DAILY	O
Dose	O
is	O
unknown,	O
please	O
continue	O
at	O
home	O
dose	O
14.	O
Multivitamins	O
1	O
TAB	O
PO	O
DAILY	O
15.	O
sitaGLIPtin	O
*NF*	O
25	O
mg	O
Oral	O
daily	O
Discharge	O
Disposition:	O
Extended	O
Care	O
Facility:	O
___	O
Discharge	O
Diagnosis:	O
Choledocolithiasis	O
Bacteremia	O
Discharge	O
Condition:	O
Mental	O
Status:	O
Clear	B-Delirium
and	B-Delirium
coherent.	B-Delirium
Level	O
of	O
Consciousness:	O
Alert	O
and	O
interactive.	O
Activity	O
Status:	O
Ambulatory	B-Mobile_with_assistance
-	B-Mobile_with_assistance
requires	B-Mobile_with_assistance
assistance	B-Mobile_with_assistance
or	O
aid	B-Mobile_with_aid
(walker	O
or	O
cane).	O
Discharge	O
Instructions:	O
Dear	O
Ms.	O
___,	O
You	O
were	O
admitted	O
to	O
the	O
___	O
for	O
an	O
ERCP	O
to	O
treat	O
your	O
gallstones	O
and	O
assess	O
for	O
the	O
cause	O
of	O
your	O
blood	O
infection.	O
The	O
procedure	O
was	O
successful	O
and	O
without	O
complication.	O
They	O
removed	O
3	O
large	O
stones	O
and	O
you	O
responded	O
well	O
to	O
the	O
procedure.	O
You	O
were	O
also	O
evaluated	O
to	O
ensure	O
that	O
there	O
was	O
not	O
an	O
infection	O
on	O
your	O
heart	O
valves.	O
You	O
underwent	O
a	O
transesophageal	O
echocardiogram	O
(TEE)	O
that	O
suggests	O
that	O
you	O
do	O
not	O
have	O
a	O
heart	O
valve	O
infection.	O
You	O
will	O
continue	O
the	O
intravenous	O
antibiotics	O
for	O
4	O
weeks	O
at	O
the	O
rehab	O
facility	O
after	O
discharge	O
and	O
follow-up	O
with	O
the	O
Infectious	O
Disease	O
team	O
as	O
an	O
outpatient.	O
You	O
declined	O
a	O
colonoscopy	O
to	O
further	O
work-up	O
your	O
bloodstream	O
infection,	O
as	O
the	O
two	O
of	O
them	O
are	O
related.	O
Your	O
outpatient	O
providers	O
___	O
continue	O
to	O
address	O
this	O
with	O
you.	O
It	O
was	O
a	O
pleasure	O
to	O
care	O
for	O
you	O
at	O
the	O
___.	O
Followup	O
Instructions:	O
___	O

